Barth Heidi, Schnober Eva K, Neumann-Haefelin Christoph, Thumann Christine, Zeisel Mirjam B, Diepolder Helmut M, Hu Zongyi, Liang T Jake, Blum Hubert E, Thimme Robert, Lambotin Mélanie, Baumert Thomas F
Department of Medicine II, University of Freiburg, Freiburg, Germany.
J Virol. 2008 Apr;82(7):3466-79. doi: 10.1128/JVI.02478-07. Epub 2008 Jan 23.
Class B scavenger receptors (SR-Bs) bind lipoproteins and play an important role in lipid metabolism. Most recently, SR-B type I (SR-BI) and its splicing variant SR-BII have been found to mediate bacterial adhesion and cytosolic bacterial invasion in mammalian cells. In this study, we demonstrate that SR-BI is a key host factor required for hepatitis C virus (HCV) uptake and cross-presentation by human dendritic cells (DCs). Whereas monocytes and T and B cells were characterized by very low or undetectable SR-BI expression levels, human DCs demonstrated a high level of cell surface expression of SR-BI similar to that of primary human hepatocytes. Antibodies targeting the extracellular loop of SR-BI efficiently inhibited HCV-like particle binding, uptake, and cross-presentation by human DCs. Moreover, human high-density lipoprotein specifically modulated HCV-like particle binding to DCs, indicating an interplay of HCV with the lipid transfer function of SR-BI in DCs. Finally, we demonstrate that anti-SR-BI antibodies inhibit the uptake of cell culture-derived HCV (HCVcc) in DCs. In conclusion, these findings identify a novel function of SR-BI for viral antigen uptake and recognition and may have an important impact on the design of HCV vaccines and immunotherapeutic approaches aiming at the induction of efficient antiviral immune responses.
B类清道夫受体(SR-Bs)可结合脂蛋白,在脂质代谢中发挥重要作用。最近,已发现I型SR-B(SR-BI)及其剪接变体SR-BII可介导哺乳动物细胞中的细菌黏附和胞质细菌入侵。在本研究中,我们证明SR-BI是人类树突状细胞(DCs)摄取丙型肝炎病毒(HCV)并进行交叉呈递所需的关键宿主因子。单核细胞以及T细胞和B细胞的特征是SR-BI表达水平非常低或无法检测到,而人类DCs表现出高水平的SR-BI细胞表面表达,类似于原代人肝细胞。靶向SR-BI细胞外环的抗体有效抑制了人类DCs对HCV样颗粒的结合、摄取和交叉呈递。此外,人类高密度脂蛋白特异性调节HCV样颗粒与DCs的结合,表明HCV与DCs中SR-BI的脂质转移功能之间存在相互作用。最后,我们证明抗SR-BI抗体可抑制DCs对细胞培养衍生的HCV(HCVcc)的摄取。总之,这些发现确定了SR-BI在病毒抗原摄取和识别方面的新功能,可能对旨在诱导有效抗病毒免疫反应的HCV疫苗和免疫治疗方法的设计产生重要影响。